{
  "docId": "019de076-862c-74eb-a1c6-035540787a6a",
  "docSlug": "0c16cbe7f9f11d0d4dde4442bc0ea51b",
  "documentTitle": "Mainz Biomed NV | Investor Presentation Deck | 24 slides",
  "authorId": "mainz-biomed-nv",
  "authorName": "Mainz Biomed",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 24,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "why_now",
  "function": "argue_timing",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "The slide uses data from a 2022 JNCI study to justify the clinical importance of AA detection sensitivity.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-862c-74eb-a1c6-035540787a6a/11",
  "deckHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a",
  "deckJsonHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a.json",
  "deckAnchorHref": "/decks/019de076-862c-74eb-a1c6-035540787a6a#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.18,
        "w": 0.43,
        "x": 0.052,
        "y": 0.00617
      },
      "kind": "callout",
      "text": "76% sensitivity for AA: Reduction in CRC incidence by 57% Reduction in CRC mortality by 67%",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4768d23e-8c56-4f68-83dd-1e120ee116ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.43,
        "x": 0.052,
        "y": 0.00425
      },
      "kind": "callout",
      "text": "21% sensitivity for AA: Reduction of CRC incidence by 30% Reduction of CRC mortality by 47%",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fcd2860a-4d32-4afe-8f83-ec0238b80c79",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.033,
        "w": 0.45,
        "x": 0.052,
        "y": 0.00383
      },
      "kind": "list",
      "text": "If a screening tests in 45yr olds and above resulted in:",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a45b37b8-790c-4025-98ef-49de51d993f7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.083,
        "w": 0.792,
        "x": 0.052,
        "y": 0.00242
      },
      "kind": "paragraph",
      "text": "Discussion of CMS decision memo on thresholds of 74% sensitivity, 90% specificity for blood-based screening for CRC. No thresholds set for detection of AA.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98256d10-46b6-45fa-af79-028661a2f367",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.052,
        "y": 0.00817
      },
      "kind": "source-note",
      "text": "Ladabaum U, et al. Counting Advanced Precancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test Specificity, JNCI: Journal of the National Cancer Institute, Volume 114, Issue 7, July 2022, Pages 1040-1043",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3834dc69-3679-44d1-898c-4b40d48a856c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.048,
        "w": 0.872,
        "x": 0.052,
        "y": 0.00155
      },
      "kind": "title",
      "text": "Including AAs detection in screening tests significantly reduces both incidence and mortality",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2826500d-60cf-4fe8-896e-916088957797",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.083,
        "w": 0.798,
        "x": 0.048,
        "y": 0.033
      },
      "kind": "title",
      "text": "Impact of AA sensitivity on CRC Mortality and Incidents Rates",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0f60e83c-7425-485d-bd41-ba90397c9ca3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "evidence-matrix",
      "slug": null,
      "matchId": "8b07f7d5-a120-4556-b9fe-368c1af5af72",
      "evidence": "Presents comparative outcomes based on sensitivity variables",
      "confidence": 0.7
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 11,
      "from": 10,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "0d79e8bd-7a15-4aa6-a038-f770860d4a0d",
      "evidence": "The problem statement and why now section emphasize the cost of inaction",
      "position": 0,
      "objective": "Highlight the importance of early CRC detection",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.8,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}